<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02881775</url>
  </required_header>
  <id_info>
    <org_study_id>16-0255</org_study_id>
    <nct_id>NCT02881775</nct_id>
  </id_info>
  <brief_title>Immediate Effects of rTMS on Excitability of the Quadriceps With Knee Osteoarthritis</brief_title>
  <official_title>Immediate Effects of rTMS on Corticospinal Excitability of the Quadriceps in People With Knee Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>North Carolina Translational and Clinical Sciences Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to identify things that influence the ability to &quot;turn on&quot; the
      thigh muscle (quadriceps). The thigh muscle tends to be under active with knee
      osteoarthritis, which may make it difficult to strengthen the muscle. The investigators are
      also testing a new technology called repetitive transcranial magnetic stimulation (rTMS) to
      determine whether it may help &quot;turn up&quot; activity in the under active thigh muscle immediately
      after its application. rTMS uses a targeted pulsed magnetic field, similar to what is used in
      an MRI (magnetic resonance imaging) machine to send an electrical signal from the brain to
      the thigh muscle.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will recruit up to 20 people with symptomatic knee osteoarthritis. The 20
      eligible participants will attend 3 sessions in the laboratory. Session 1 is to collect data
      for Aim 1. Sessions 2 and 3 will include the rTMS interventions and data collection for Aim
      2.

      Aim 1 is a descriptive study to compare the neural (cortical and corticospinal) excitability
      of the quadriceps in the symptomatic knee to the asymptomatic knee in participants with knee
      osteoarthritis. The investigators will examine the associations between neural excitability
      and clinical measures of pain, strength, function, and coping styles.

      Aim 2 is a double blind, crossover study design. Each participant will partake in two testing
      sessions, spaced 1 week apart. The investigators will evaluate outcome measures prior to and
      following the &quot;true&quot; intervention versus the &quot;sham&quot; intervention. The true intervention is
      rTMS + exercise. The sham is sham rTMS + exercise. The primary outcome measures are
      quadriceps strength, as measured from a maximal isometric voluntary contraction, and
      quadriceps central activation ratio (CAR), as calculated from the torque values from the
      voluntary strength measurement and a brief, intense electrical stimulus. Secondary measures
      evaluate effects of the intervention on 1) clinical measures of pain and functional
      performance, 2) corticospinal excitability, and 3) intracortical inhibition and facilitation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Actual">June 26, 2018</completion_date>
  <primary_completion_date type="Actual">June 26, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quadriceps Central Activation Ratio (CAR)</measure>
    <time_frame>Within 1 hour post intervention</time_frame>
    <description>Quadriceps Central Activation Ratio (CAR) is a percentage of the amount of torque produced during the superimposed burst technique using maximal voluntary isometric contraction (MVIC) and superimposed burst torque. It is reported on a scale of 0 (worst) to 100% (best) activation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quadriceps Maximal Voluntary Isometric Contraction (MVIC)</measure>
    <time_frame>Within 1 hour post intervention</time_frame>
    <description>HUMAC NORM electromechanical dynamometer is used to measure isometric torque generation in quadriceps muscle stabilized with 70 degrees of knee flexion. Units of measure are in Newton meters (Nm).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numeric Pain Rating Scale (NPRS) Score</measure>
    <time_frame>Within 1 hour post intervention</time_frame>
    <description>Pain intensity is rated on a visual analog scale of 0-10 where 0 is no pain and 10 is maximum pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure Pain Threshold (PPT) - Medial Knee</measure>
    <time_frame>Within 1 hour post intervention</time_frame>
    <description>Using the AlgoMed algometer, pressure at a rate of 35 kPA/second is applied to the medial knee to the level that subject indicates is painful. Units of measure are kilopascal (kPa)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Timed Up &amp; Go (TUG)</measure>
    <time_frame>Within 1 hour post intervention</time_frame>
    <description>Time in seconds to rise from a chair, walk 3 m, return and sit down</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Active Motor Threshold Motor Evoked Potential (AMT-MEP)</measure>
    <time_frame>Within 1 hour post intervention</time_frame>
    <description>The quadriceps active muscle responses (motor evoked potentials) that result from the single-pulse transcranial magnetic stimulation (TMS) pulses over the motor cortex. These AMT-MEP are measured peak-to-peak in microvolts (uV ). 10 AMT-MEP values were collected and averaged.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short Interval Cortical Inhibition (SICI)</measure>
    <time_frame>Within 1 hour post intervention</time_frame>
    <description>Transcranial magnetic stimulation (TMS), using the conditioning-test paired-pulse paradigm with a 3 ms interval, will be used. SICI is the ratio of the conditioning stimulus relative to the test stimulus. A ratio &lt; 1.0 indicates inhibition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra Cortical Facilitation (ICF)</measure>
    <time_frame>Within 1 hour post intervention</time_frame>
    <description>Transcranial magnetic stimulation (TMS), using the conditioning-test paired-pulse paradigm with a 15 ms interval, will be used. ICF is the ratio of the conditioning stimulus relative to the test stimulus. A ratio &gt; 1.0 indicates facilitation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>rTMS and exercise, then Sham rTMS and exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>At lab visit, subjects receive repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive sham rTMS and exercise using the same parameters.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham rTMS and exercise, then rTMS and exercise</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>At lab visit, subjects receive sham repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive the &quot;true&quot; rTMS and exercise using the same parameters.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rTMS and exercise</intervention_name>
    <description>rTMS at 10 Hz (5 sec on, 55 sec off) and light quadriceps isometric exercise (5% MVIC)</description>
    <arm_group_label>Sham rTMS and exercise, then rTMS and exercise</arm_group_label>
    <arm_group_label>rTMS and exercise, then Sham rTMS and exercise</arm_group_label>
    <other_name>repetitive TMS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham rTMS and exercise</intervention_name>
    <description>rTMS unit is on and running but mu metal is placed between the coil and the skull</description>
    <arm_group_label>Sham rTMS and exercise, then rTMS and exercise</arm_group_label>
    <arm_group_label>rTMS and exercise, then Sham rTMS and exercise</arm_group_label>
    <other_name>sham repetitive TMS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  symptomatic knee osteoarthritis primarily involving one leg based on Western Ontario
             and McMaster Universities Arthritis Index (WOMAC) function subscale score &gt; 10 (out of
             100 points, indicating most dysfunction)

          -  diagnosis of knee osteoarthritis

          -  opposite knee with WOMAC pain score â‰¤ 5.

          -  opposite knee does not have a diagnosis of knee osteoarthritis

        Exclusion Criteria:

          -  conditions affecting the leg other than osteoarthritis

          -  low blood pressure (&lt; 90 systolic, 60 diastolic) or heart rate (&lt; 60 beats per minute)

          -  conditions that limit exercise tolerance such as a heart condition

          -  pregnant or planning to become pregnant in the next 3 months

          -  conditions that alter sensation and pain processing

          -  BMI &gt; 35

          -  severe arthritis in both knees

          -  history of leg or back surgery in the past year or knee replacement surgery;

          -  injection in the knee joint in the past 4 weeks

          -  requires an assistive device to walk

          -  any contraindications for TMS or rTMS (seizures, metal implants in head, brain related
             conditions, brain injury, drug or alcohol withdrawal)

          -  medications that lower seizure threshold

          -  history of fainting spells (syncope) or low blood pressure

          -  sleep deprived

          -  inability to understand and repeat back directions regarding the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Deborah L Givens, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of North Carolina - Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>August 15, 2016</study_first_submitted>
  <study_first_submitted_qc>August 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2016</study_first_posted>
  <results_first_submitted>May 2, 2019</results_first_submitted>
  <results_first_submitted_qc>May 2, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 29, 2019</results_first_posted>
  <last_update_submitted>May 28, 2019</last_update_submitted>
  <last_update_submitted_qc>May 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>TMS</keyword>
  <keyword>rTMS</keyword>
  <keyword>corticospinal</keyword>
  <keyword>quadriceps</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 1, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/75/NCT02881775/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>rTMS and Exercise, Then Sham rTMS and Exercise</title>
          <description>At lab visit, subjects receive repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive sham rTMS and exercise using the same parameters.
rTMS and exercise: rTMS at 10 Hz (5 sec on, 55 sec off) and light quadriceps isometric exercise (5% MVIC)
Sham rTMS and exercise: rTMS unit is on and running but mu metal is placed between the coil and the skull</description>
        </group>
        <group group_id="P2">
          <title>Sham rTMS and Exercise, Then rTMS and Exercise</title>
          <description>At lab visit, subjects receive sham repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive the &quot;true&quot; rTMS and exercise using the same parameters.
rTMS and exercise: rTMS at 10 Hz (5 sec on, 55 sec off) and light quadriceps isometric exercise (5% MVIC)
Sham rTMS and exercise: rTMS unit is on and running but mu metal is placed between the coil and the skull</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Baseline</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>First Intervention (1-hr Session)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9">Two participants dropped out prior to First Intervention (1-hr Session).</participants>
                <participants group_id="P2" count="7">Two participants dropped out prior to First Intervention (1-hr Session).</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout (1 Week)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention (1-Hour Session)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants in the baseline population are the same as those in the intervention. All participants came for 3 laboratory sessions. The purpose of the first session was to collect baseline data on both the involved and uninvolved knee.</population>
      <group_list>
        <group group_id="B1">
          <title>All Study Participants</title>
          <description>Participants who were randomized to receive either rTMS and exercise or sham rTMS and exercise.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <description>intake questionnaire</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Quadriceps Central Activation Ratio (CAR)</title>
        <description>Quadriceps Central Activation Ratio (CAR) is a percentage of the amount of torque produced during the superimposed burst technique using maximal voluntary isometric contraction (MVIC) and superimposed burst torque. It is reported on a scale of 0 (worst) to 100% (best) activation.</description>
        <time_frame>Within 1 hour post intervention</time_frame>
        <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study. Four subjects declined to perform the test after the experience with the electrical stimulus in the baseline session.</population>
        <group_list>
          <group group_id="O1">
            <title>rTMS and Exercise</title>
            <description>At lab visit, subjects receive repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive sham rTMS and exercise using the same parameters.</description>
          </group>
          <group group_id="O2">
            <title>Sham rTMS and Exercise</title>
            <description>At lab visit, subjects receive sham repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive the &quot;true&quot; rTMS and exercise using the same parameters.</description>
          </group>
        </group_list>
        <measure>
          <title>Quadriceps Central Activation Ratio (CAR)</title>
          <description>Quadriceps Central Activation Ratio (CAR) is a percentage of the amount of torque produced during the superimposed burst technique using maximal voluntary isometric contraction (MVIC) and superimposed burst torque. It is reported on a scale of 0 (worst) to 100% (best) activation.</description>
          <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study. Four subjects declined to perform the test after the experience with the electrical stimulus in the baseline session.</population>
          <units>% activation</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CAR Baseline (BL)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.3554" spread="3.2921"/>
                    <measurement group_id="O2" value="86.1983" spread="3.2921"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CAR BL Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2496" spread="2.1397"/>
                    <measurement group_id="O2" value="-1.2670" spread="2.1397"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison of CAR BL Change (treatment by time)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.9994</p_value>
            <p_value_desc>The threshold for significance was P &lt;.05</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Repeated measures ANOVA with restricted maximum likelihood estimation and Kenward-Roger standard errors.
Degrees of freedom (DF) = 34.1</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Quadriceps Maximal Voluntary Isometric Contraction (MVIC)</title>
        <description>HUMAC NORM electromechanical dynamometer is used to measure isometric torque generation in quadriceps muscle stabilized with 70 degrees of knee flexion. Units of measure are in Newton meters (Nm).</description>
        <time_frame>Within 1 hour post intervention</time_frame>
        <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study.</population>
        <group_list>
          <group group_id="O1">
            <title>rTMS and Exercise</title>
            <description>At lab visit, subjects receive repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive sham rTMS and exercise using the same parameters.</description>
          </group>
          <group group_id="O2">
            <title>Sham rTMS and Exercise</title>
            <description>At lab visit, subjects receive sham repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive the &quot;true&quot; rTMS and exercise using the same parameters.</description>
          </group>
        </group_list>
        <measure>
          <title>Quadriceps Maximal Voluntary Isometric Contraction (MVIC)</title>
          <description>HUMAC NORM electromechanical dynamometer is used to measure isometric torque generation in quadriceps muscle stabilized with 70 degrees of knee flexion. Units of measure are in Newton meters (Nm).</description>
          <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study.</population>
          <units>Nm</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>MVIC Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="129.46" spread="11.8464"/>
                    <measurement group_id="O2" value="129.09" spread="11.8464"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MVIC BL Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.3473" spread="4.4266"/>
                    <measurement group_id="O2" value="-6.1643" spread="4.4266"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison of MVIC BL Change (treatment by time)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.9768</p_value>
            <p_value_desc>The threshold for statistical significance was p &lt; .05</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Repeated measures ANOVA with restricted maximum likelihood estimation and Kenward-Roger standard errors. DF = 45</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Numeric Pain Rating Scale (NPRS) Score</title>
        <description>Pain intensity is rated on a visual analog scale of 0-10 where 0 is no pain and 10 is maximum pain</description>
        <time_frame>Within 1 hour post intervention</time_frame>
        <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study. For two subjects, the research assistant missed obtaining the post-intervention pain rating.</population>
        <group_list>
          <group group_id="O1">
            <title>rTMS and Exercise</title>
            <description>At lab visit, subjects receive repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive sham rTMS and exercise using the same parameters.</description>
          </group>
          <group group_id="O2">
            <title>Sham rTMS and Exercise</title>
            <description>At lab visit, subjects receive sham repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive the &quot;true&quot; rTMS and exercise using the same parameters.</description>
          </group>
        </group_list>
        <measure>
          <title>Numeric Pain Rating Scale (NPRS) Score</title>
          <description>Pain intensity is rated on a visual analog scale of 0-10 where 0 is no pain and 10 is maximum pain</description>
          <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study. For two subjects, the research assistant missed obtaining the post-intervention pain rating.</population>
          <units>score on scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>NPRS Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.25" spread=".5749"/>
                    <measurement group_id="O2" value="3.000" spread=".5749"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NPRS BL Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.625" spread=".4187"/>
                    <measurement group_id="O2" value="-.1570" spread=".4378"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison of NPRS BL Change (treatment by time)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4440</p_value>
            <p_value_desc>threshold for statistical significance is p &lt; .05</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Repeated measures ANOVA with restricted maximum likelihood estimation and Kenward-Roger standard errors. DF = 43.1</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pressure Pain Threshold (PPT) - Medial Knee</title>
        <description>Using the AlgoMed algometer, pressure at a rate of 35 kPA/second is applied to the medial knee to the level that subject indicates is painful. Units of measure are kilopascal (kPa)</description>
        <time_frame>Within 1 hour post intervention</time_frame>
        <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study.</population>
        <group_list>
          <group group_id="O1">
            <title>rTMS and Exercise</title>
            <description>At lab visit, subjects receive repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive sham rTMS and exercise using the same parameters.</description>
          </group>
          <group group_id="O2">
            <title>Sham rTMS and Exercise</title>
            <description>At lab visit, subjects receive sham repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive the &quot;true&quot; rTMS and exercise using the same parameters.</description>
          </group>
        </group_list>
        <measure>
          <title>Pressure Pain Threshold (PPT) - Medial Knee</title>
          <description>Using the AlgoMed algometer, pressure at a rate of 35 kPA/second is applied to the medial knee to the level that subject indicates is painful. Units of measure are kilopascal (kPa)</description>
          <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study.</population>
          <units>kPa</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PPT Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="402.41" spread="60.1780"/>
                    <measurement group_id="O2" value="419.21" spread="60.1780"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PPT BL Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.8583" spread="28.0167"/>
                    <measurement group_id="O2" value="4.3548" spread="28.0167"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>PPT BL Change (treatment by time)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.6608</p_value>
            <p_value_desc>Threshold for statistical significance is P &lt; .05</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Repeated measures ANOVA with restricted maximum likelihood estimation and Kenward-Roger standard errors. DF = 45</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Timed Up &amp; Go (TUG)</title>
        <description>Time in seconds to rise from a chair, walk 3 m, return and sit down</description>
        <time_frame>Within 1 hour post intervention</time_frame>
        <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study.</population>
        <group_list>
          <group group_id="O1">
            <title>rTMS and Exercise</title>
            <description>At lab visit, subjects receive repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive sham rTMS and exercise using the same parameters.</description>
          </group>
          <group group_id="O2">
            <title>Sham rTMS and Exercise</title>
            <description>At lab visit, subjects receive sham repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive the &quot;true&quot; rTMS and exercise using the same parameters.</description>
          </group>
        </group_list>
        <measure>
          <title>Timed Up &amp; Go (TUG)</title>
          <description>Time in seconds to rise from a chair, walk 3 m, return and sit down</description>
          <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study.</population>
          <units>seconds</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>TUG Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3919" spread=".4079"/>
                    <measurement group_id="O2" value="8.3056" spread=".4079"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TUG BL Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.08021" spread=".803"/>
                    <measurement group_id="O2" value="-.00542" spread=".1803"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison of TUG BL Change (treatment by time)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.7706</p_value>
            <p_value_desc>Threshold for statistical significance is P &lt; .05</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Repeated measures ANOVA with restricted maximum likelihood estimation and Kenward-Roger standard errors. DF = 45</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Active Motor Threshold Motor Evoked Potential (AMT-MEP)</title>
        <description>The quadriceps active muscle responses (motor evoked potentials) that result from the single-pulse transcranial magnetic stimulation (TMS) pulses over the motor cortex. These AMT-MEP are measured peak-to-peak in microvolts (uV ). 10 AMT-MEP values were collected and averaged.</description>
        <time_frame>Within 1 hour post intervention</time_frame>
        <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study. A technical issue in how the TMS unit worked was discovered after collecting the first 4 subjects in the intervention part of the study. This impacted their AMT-MEP, ICF, and SICI data which were excluded from the analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>rTMS and Exercise</title>
            <description>At lab visit, subjects receive repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive sham rTMS and exercise using the same parameters.</description>
          </group>
          <group group_id="O2">
            <title>Sham rTMS and Exercise</title>
            <description>At lab visit, subjects receive sham repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive the &quot;true&quot; rTMS and exercise using the same parameters.</description>
          </group>
        </group_list>
        <measure>
          <title>Active Motor Threshold Motor Evoked Potential (AMT-MEP)</title>
          <description>The quadriceps active muscle responses (motor evoked potentials) that result from the single-pulse transcranial magnetic stimulation (TMS) pulses over the motor cortex. These AMT-MEP are measured peak-to-peak in microvolts (uV ). 10 AMT-MEP values were collected and averaged.</description>
          <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study. A technical issue in how the TMS unit worked was discovered after collecting the first 4 subjects in the intervention part of the study. This impacted their AMT-MEP, ICF, and SICI data which were excluded from the analyses.</population>
          <units>uV</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>AMT-MEP Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".1387" spread=".009634"/>
                    <measurement group_id="O2" value=".1434" spread=".009634"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AMT-MEP BL Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.00007" spread=".01107"/>
                    <measurement group_id="O2" value="-.01441" spread=".01107"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison of AMT-MEP BL Change (treatment by time)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.3665</p_value>
            <p_value_desc>Threshold for statistical significance is P &lt; .05</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Repeated measures ANOVA with restricted maximum likelihood estimation and Kenward-Roger standard errors. DF = 33</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Short Interval Cortical Inhibition (SICI)</title>
        <description>Transcranial magnetic stimulation (TMS), using the conditioning-test paired-pulse paradigm with a 3 ms interval, will be used. SICI is the ratio of the conditioning stimulus relative to the test stimulus. A ratio &lt; 1.0 indicates inhibition.</description>
        <time_frame>Within 1 hour post intervention</time_frame>
        <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study. A technical issue in how the TMS unit worked was discovered after collecting the first 4 subjects in the intervention part of the study. This impacted their AMT-MEP, ICF, and SICI data which were excluded from the analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>rTMS and Exercise</title>
            <description>At lab visit, subjects receive repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive sham rTMS and exercise using the same parameters.</description>
          </group>
          <group group_id="O2">
            <title>Sham rTMS and Exercise</title>
            <description>At lab visit, subjects receive sham repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive the &quot;true&quot; rTMS and exercise using the same parameters.</description>
          </group>
        </group_list>
        <measure>
          <title>Short Interval Cortical Inhibition (SICI)</title>
          <description>Transcranial magnetic stimulation (TMS), using the conditioning-test paired-pulse paradigm with a 3 ms interval, will be used. SICI is the ratio of the conditioning stimulus relative to the test stimulus. A ratio &lt; 1.0 indicates inhibition.</description>
          <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study. A technical issue in how the TMS unit worked was discovered after collecting the first 4 subjects in the intervention part of the study. This impacted their AMT-MEP, ICF, and SICI data which were excluded from the analyses.</population>
          <units>ratio</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>SICI Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".5140" spread=".054"/>
                    <measurement group_id="O2" value=".5996" spread=".1054"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SICI BL Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.02588" spread=".07227"/>
                    <measurement group_id="O2" value="-.1151" spread=".07227"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison of SICI BL Change (treatment by time)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.3889</p_value>
            <p_value_desc>Threshold for statistical significance is P &lt; .05</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Repeated measures ANOVA with restricted maximum likelihood estimation and Kenward-Roger standard errors. DF = 33</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intra Cortical Facilitation (ICF)</title>
        <description>Transcranial magnetic stimulation (TMS), using the conditioning-test paired-pulse paradigm with a 15 ms interval, will be used. ICF is the ratio of the conditioning stimulus relative to the test stimulus. A ratio &gt; 1.0 indicates facilitation.</description>
        <time_frame>Within 1 hour post intervention</time_frame>
        <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study. A technical issue in how the TMS unit worked was discovered after collecting the first 4 subjects in the intervention part of the study. This impacted their AMT-MEP, ICF, and SICI data which were excluded from the analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>rTMS and Exercise</title>
            <description>At lab visit, subjects receive repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive sham rTMS and exercise using the same parameters.</description>
          </group>
          <group group_id="O2">
            <title>Sham rTMS and Exercise</title>
            <description>At lab visit, subjects receive sham repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive the &quot;true&quot; rTMS and exercise using the same parameters.</description>
          </group>
        </group_list>
        <measure>
          <title>Intra Cortical Facilitation (ICF)</title>
          <description>Transcranial magnetic stimulation (TMS), using the conditioning-test paired-pulse paradigm with a 15 ms interval, will be used. ICF is the ratio of the conditioning stimulus relative to the test stimulus. A ratio &gt; 1.0 indicates facilitation.</description>
          <population>4 subjects withdrew from the study after the baseline measures. This left 16 subjects for the intervention arm of the study. A technical issue in how the TMS unit worked was discovered after collecting the first 4 subjects in the intervention part of the study. This impacted their AMT-MEP, ICF, and SICI data which were excluded from the analyses.</population>
          <units>ratio</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ICF Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.193" spread=".903"/>
                    <measurement group_id="O2" value=".904" spread=".903"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ICF BL Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.0354" spread=".1896"/>
                    <measurement group_id="O2" value=".03042" spread=".1896"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison of ICF BL Change (treatment by time)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.2192</p_value>
            <p_value_desc>Threshold for statistical significance is P &lt; .05</p_value_desc>
            <method>ANOVA</method>
            <method_desc>Repeated measures ANOVA with restricted maximum likelihood estimation and Kenward-Roger standard errors. DF = 33</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From Baseline (Enrollment) until the end of Session 2, a total of approximately 3 weeks.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>rTMS and Exercise</title>
          <description>At lab visit, subjects receive repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive sham rTMS and exercise using the same parameters.</description>
        </group>
        <group group_id="E2">
          <title>Sham rTMS and Exercise</title>
          <description>At lab visit, subjects receive sham repetitive transcranial magnetic stimulation (rTMS) at 10 Hz, 5 sec on, 55 sec off and quadriceps isometric exercise (5% MVIC) for 15 minutes. This is followed by a wash out period of 1 week. At the next lab visit, subjects receive the &quot;true&quot; rTMS and exercise using the same parameters.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Deborah Givens, PhD</name_or_title>
      <organization>University of North Carolina at Chapel Hill</organization>
      <phone>919-843-8660</phone>
      <email>deborah_givens@med.unc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

